FHS-25166-66285
5 vaccinations
4 coded responses
36 check-ins
4 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 970 / OR
- Registered
- 2021-02-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-02-10
Registered in v-safe
-
2021-02-10
Dose 1 — Pfizer-BioNTech
- 2021-02-10
- 2021-02-11
- 2021-02-12
- 2021-02-13
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-24
- 2021-03-03
-
2021-03-04
Dose 2 — Pfizer-BioNTech
-
2021-03-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-07
- 2021-03-08
- 2021-03-09
-
2021-03-10
Survey response — days 1–6 daily, dose 2MedDRA: Anxiety — Feeling: Poor · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Heightened anxietyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-10
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-11
Survey response — day 7, dose 2MedDRA: Anxiety — Feeling: Fair · Nausea · Be unable to do your normal daily activitiesFree text: AnxietyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-18
- 2021-03-26
- 2021-04-01
- 2021-04-08
- 2021-04-15
- 2021-06-05
- 2021-09-02
-
2021-11-23
Dose 3 — Pfizer-BioNTech
- 2021-11-30
- 2021-12-07
- 2021-12-14
-
2021-12-20
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-12-21
- 2021-12-28
- 2022-01-04
- 2022-02-22
- 2022-05-24
-
2022-08-24
Dose 4 — Pfizer-BioNTech
-
2022-10-28
Dose 5 — Pfizer-BioNTech
-
2022-11-23
Survey response — 12 months, dose 3MedDRA: Ageusia, Anosmia, COVID-19, Fatigue, Headache, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: COVID positive, fatigue, congestion, runny nose, headaches, loss of smell, and taste.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-23
Survey response — day 21, dose 5MedDRA: Sleep apnoea syndrome, Type 1 diabetes mellitus — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Sleep apnea, type 1 diabetes.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-23
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-11-23
Report sent to call center — day 21, dose 5Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-11-25
- 2022-11-25
- 2022-11-25
- 2022-12-06
- 2023-04-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-10 | Pfizer-BioNTech | |
| 2 | 2021-03-04 | Pfizer-BioNTech | |
| 3 | 2021-11-23 | Pfizer-BioNTech | No |
| 4 | 2022-08-24 | Pfizer-BioNTech | No |
| 5 | 2022-10-28 | Pfizer-BioNTech | No |
Call center
3 call center cases
1 successful · 2 unsuccessful
Free text
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Heightened anxiety
Release 5 — day 7, dose 2
Systemic reaction (other): Anxiety
Release 12 — 12 months, dose 3
Symptoms: COVID positive, fatigue, congestion, runny nose, headaches, loss of smell, and taste.
Release 12 — day 21, dose 5
Symptoms: Sleep apnea, type 1 diabetes.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sleep apnoea syndrome | · | · | ✓ |
| SD | Type 1 diabetes mellitus | · | · | ✓ |
| SRO | Anxiety | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release